These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 31406207)
1. Exosomal miR-16-5p as a target for malignant mesothelioma. Munson PB; Hall EM; Farina NH; Pass HI; Shukla A Sci Rep; 2019 Aug; 9(1):11688. PubMed ID: 31406207 [TBL] [Abstract][Full Text] [Related]
2. Tuberculous Pleural Effusion-Derived Exosomal miR-130b-3p and miR-423-5p Promote the Proliferation of Lung Cancer Cells via Cyclin D1. Kang HJ; Yun S; Shin SH; Youn DH; Son GH; Lee JJ; Hong JY Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337604 [TBL] [Abstract][Full Text] [Related]
3. Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance. Yao S; Yin Y; Jin G; Li D; Li M; Hu Y; Feng Y; Liu Y; Bian Z; Wang X; Mao Y; Zhang J; Wu Z; Huang Z Cancer Med; 2020 Aug; 9(16):5989-5998. PubMed ID: 32618144 [TBL] [Abstract][Full Text] [Related]
5. KCa1.1, a calcium-activated potassium channel subunit alpha 1, is targeted by miR-17-5p and modulates cell migration in malignant pleural mesothelioma. Cheng YY; Wright CM; Kirschner MB; Williams M; Sarun KH; Sytnyk V; Leshchynska I; Edelman JJ; Vallely MP; McCaughan BC; Klebe S; van Zandwijk N; Lin RC; Reid G Mol Cancer; 2016 Jun; 15(1):44. PubMed ID: 27245839 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin-resistant lung cancer cell-derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100-5p-dependent manner. Qin X; Yu S; Zhou L; Shi M; Hu Y; Xu X; Shen B; Liu S; Yan D; Feng J Int J Nanomedicine; 2017; 12():3721-3733. PubMed ID: 28553110 [TBL] [Abstract][Full Text] [Related]
7. miR-380-5p-mediated repression of TEP1 and TSPYL5 interferes with telomerase activity and favours the emergence of an "ALT-like" phenotype in diffuse malignant peritoneal mesothelioma cells. Cimino-Reale G; Gandellini P; Santambrogio F; Recagni M; Zaffaroni N; Folini M J Hematol Oncol; 2017 Jul; 10(1):140. PubMed ID: 28716051 [TBL] [Abstract][Full Text] [Related]
8. Exosome-Mediated miR-21 Was Involved in the Promotion of Structural and Functional Recovery Effect Produced by Electroacupuncture in Sciatic Nerve Injury. Liu YP; Yang YD; Mou FF; Zhu J; Li H; Zhao TT; Zhao Y; Shao SJ; Cui GH; Guo HD Oxid Med Cell Longev; 2022; 2022():7530102. PubMed ID: 35132352 [TBL] [Abstract][Full Text] [Related]
9. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4. Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570 [TBL] [Abstract][Full Text] [Related]
10. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells. Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333 [TBL] [Abstract][Full Text] [Related]
11. miR-134 in extracellular vesicles reduces triple-negative breast cancer aggression and increases drug sensitivity. O'Brien K; Lowry MC; Corcoran C; Martinez VG; Daly M; Rani S; Gallagher WM; Radomski MW; MacLeod RA; O'Driscoll L Oncotarget; 2015 Oct; 6(32):32774-89. PubMed ID: 26416415 [TBL] [Abstract][Full Text] [Related]
12. Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets. Choi KH; Shin CH; Lee WJ; Ji H; Kim HH Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31262974 [TBL] [Abstract][Full Text] [Related]
13. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation. Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720 [TBL] [Abstract][Full Text] [Related]
14. Luteolin Inhibits Tumorigenesis and Induces Apoptosis of Non-Small Cell Lung Cancer Cells via Regulation of MicroRNA-34a-5p. Jiang ZQ; Li MH; Qin YM; Jiang HY; Zhang X; Wu MH Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29393891 [TBL] [Abstract][Full Text] [Related]
15. miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1. Tong Z; Liu N; Lin L; Guo X; Yang D; Zhang Q Biomed Pharmacother; 2015 Oct; 75():129-36. PubMed ID: 26297542 [TBL] [Abstract][Full Text] [Related]
16. miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma. Williams M; Kirschner MB; Cheng YY; Hanh J; Weiss J; Mugridge N; Wright CM; Linton A; Kao SC; Edelman JJ; Vallely MP; McCaughan BC; Cooper W; Klebe S; Lin RC; Brahmbhatt H; MacDiarmid J; van Zandwijk N; Reid G Oncotarget; 2015 Sep; 6(27):23480-95. PubMed ID: 26125439 [TBL] [Abstract][Full Text] [Related]
17. Down-regulation of c-Met and Bcl2 by microRNA-206, activates apoptosis, and inhibits tumor cell proliferation, migration and colony formation. Sun C; Liu Z; Li S; Yang C; Xue R; Xi Y; Wang L; Wang S; He Q; Huang J; Xie S; Jiang W; Li D Oncotarget; 2015 Sep; 6(28):25533-74. PubMed ID: 26325180 [TBL] [Abstract][Full Text] [Related]
18. Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication. Monaco F; Gaetani S; Alessandrini F; Tagliabracci A; Bracci M; Valentino M; Neuzil J; Amati M; Bovenzi M; Tomasetti M; Santarelli L Cancer Lett; 2019 Oct; 463():27-36. PubMed ID: 31400405 [TBL] [Abstract][Full Text] [Related]
19. Exosome miR-371b-5p promotes proliferation of lung alveolar progenitor type II cells by using PTEN to orchestrate the PI3K/Akt signaling. Quan Y; Wang Z; Gong L; Peng X; Richard MA; Zhang J; Fornage M; Alcorn JL; Wang D Stem Cell Res Ther; 2017 Jun; 8(1):138. PubMed ID: 28595637 [TBL] [Abstract][Full Text] [Related]
20. Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma. Johnson TG; Schelch K; Cheng YY; Williams M; Sarun KH; Kirschner MB; Kao S; Linton A; Klebe S; McCaughan BC; Lin RCY; Pirker C; Berger W; Lasham A; van Zandwijk N; Reid G J Thorac Oncol; 2018 Feb; 13(2):258-272. PubMed ID: 29113949 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]